Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET

INTRODUCTION: A combination of carboplatin and paclitaxel is often used as first line chemotherapy for treatment of ovarian cancer. Therefore the use of imaging biomarkers early after initiation of treatment to determine treatment sensitivity would be valuable in order to identify responders from no...

Descripción completa

Detalles Bibliográficos
Autores principales: Munk Jensen, Mette, Erichsen, Kamille Dumong, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Sehested, Maxwell, Højgaard, Liselotte, Kjær, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873431/
https://www.ncbi.nlm.nih.gov/pubmed/24386456
http://dx.doi.org/10.1371/journal.pone.0085126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873431/
https://www.ncbi.nlm.nih.gov/pubmed/24386456
http://dx.doi.org/10.1371/journal.pone.0085126

Ejemplares similares